Neuphoria Therapeutics Inc (NEUP) institutional holders · rev $1.2M
Neuphoria Therapeutics Inc institutional holders from SEC Form 13F, top 1 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| CITADEL ADVISORS LLC | 19,331 | $78.7K | 2026-03-31Prior quarter |
NEUP institutional holders FAQ
What is NEUP's latest revenue?
Latest cached Neuphoria Therapeutics Inc (NEUP) revenue for Jun 30, 2026 was $1.2M. Statements: https://lician.com/financials/neup
Not investment advice. Figures as filed or reported, not a live feed.